Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

Advancements in cell and gene therapy have been driven by improved insights into the human immune system and a better ...

Kendric Cromer undergoing infusion gene therapy for his sickle cell disease at Children’s National Hospital in Washington last week.Credit...Kenny Holston/The New York Times Supported by By Gina ...

9, 2024 — Scientists developed a highly promising gene therapy to treat glaucoma -- a ... Editing System Makes Gene-Sized Edits in Human Cells at Therapeutic Levels June 10, 2024 — Scientists ...

A new editorial was published in Oncoscience (Volume 11) on July 13, 2024, entitled, "Unveiling retrotransposon-derived DNA zip code for myeloma cell internalization." Gene therapy could ...

“These partnered programs provide multiple opportunities for success and complement our wholly-owned pipeline, including our SOD1 ALS gene therapy program ... of AAV by Cell-type-specific ...

The Buy rating was heavily influenced by the FDA’s grant of the Regenerative Medicine Advanced Therapy (RMAT) designation to BBP-812, an investigational gene therapy for Canavan disease.

Tesla has announced that it produced its 100 millionth 4680 battery cell. Here’s what it means for its production growth. The 4680 battery cell is a new format, 46mm x 80mm, enabled by a few new ...

Gene delivery is a process by which foreign DNA is transferred to host cells for applications such as genetic research or gene therapy. Gene delivery methods can be mechanical (e.g. microinjection ...